I don’t expect the Copaxone trial to be delayed until 2012, although I suppose it’s possible.
On a related note, Bill Marth claimed on a webcast in September that the Copaxone patent case was effectively decided in Teva’s favor already and that Teva would probably file a motion for a summary judgment that the patents are valid and infringed.
Has anyone seen such a motion? (Rhetorical question.)
Market Data 
Markets 
AI
